Recursion is a clinical-stage biotech firm using AI, machine learning, and automation to accelerate drug discovery.
/Nvidia%20logo%20and%20sign%20on%20headquarters%20by%20Michael%20Vi%20via%20Shutterstock.jpg)
Down 25% from all-time highs, Nvidia is a tech stock that trades at a sizeable discount to consensus price target estimates in March 2025.
The popular investor poured $366.2 million in the company’s shares to carry out her latest purchase.
Leerink cited concerns over high cash burn and execution risks in deal-making and clinical development over the next year.
Analyst Timothy Arcuri believes the chip giant's results will exceed expectations.
/Microsoft%20sign%20at%20the%20headquarters%20by%20VDB%20Photos%20via%20Shutterstock.jpg)
Concerns over AI data center capacity are weighing on MSFT stock, despite last week's game-changing quantum chip breakthrough.
/Technology%20by%20Alexandre%20Debieve%20via%20Unsplash.jpg)
Arm is a high-flying chip stock that trades at a lofty multiple in 2025. Is the semiconductor company a good investment at current levels?
The Japanese conglomerate’s bet comes amid growing AI sector momentum, fueled in part by chipmaking giant Nvidia, which also holds over 7.7 million Recursion shares.
/NVIDIA%20Corp%20logo%20on%20phone%20and%20AI%20chip-by%20Below%20the%20Sky%20via%20Shutterstock.jpg)
Down 11% from all-time highs, Nvidia stock trades at a reasonable valuation in 2025. However, the chip maker continues to wrestle with multiple headwinds that might impact its financials in the near term....
The Vanguard S&P 500 ETF (VOO) is a top pick for investors who believe in Elon Musk's vision for a tech-driven America.